Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, Massachusetts
- Most recent report
- 10-Q, filed Nov 3, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1162194
- Fiscal year ends
- December
- Filer status
- Accelerated filer
Financials 8 of 45
News 8 of 152
- 8-K Current report on a material event Nov 3, 2026
- 8-K Current report on a material event Oct 5, 2026
- 8-K Significant contract Sep 30, 2026
- 8-K Quarterly results Aug 5, 2026
- 8-K/A Current report on a material event, amended Jul 29, 2026
- 8-K Significant contract Jul 28, 2026
- 8-K Current report on a material event Jul 24, 2026
- 8-K Leadership change Jun 18, 2026
Prospectuses and Registrations 8 of 41
- 424B3 Prospectus supplement for an offering Oct 30, 2026
- 424B3 Prospectus supplement for an offering Oct 21, 2026
- S-4/A Registration statement for a merger or exchange, amended Oct 21, 2026
- S-4/A Registration statement for a merger or exchange, amended Oct 9, 2026
- S-4/A Registration statement for a merger or exchange, amended Sep 9, 2026
- S-8 Registration statement for an employee plan Aug 5, 2026
- S-8 Registration statement for an employee plan Aug 5, 2026
- S-4 Registration statement for a merger or exchange Jul 20, 2026
Proxies 8 of 37
- DEFA14A Extra proxy material Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- DEFA14A Extra proxy material Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- DEFA14A Extra proxy material Jun 3, 2024
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
- DEFA14A Extra proxy material Apr 29, 2022
Ownership 8 of 657
- 4 Insider reported a trade Nov 5, 2026
- 4 Insider reported a trade Aug 24, 2026
- 4 Insider reported a trade Aug 24, 2026
- 4 Insider reported a trade Aug 24, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 4 Insider reported a trade Aug 4, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 30, 2026
Other 8 of 68
Everything here comes from Standard Biotools Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.